Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: preliminary results of a phase II and pharmacogenomic study.
暂无分享,去创建一个
P. Sánchez‐Rovira | M. Dómine | I. Calvo | L. Estévez | A. Jaén | G. Rubio | F. Lobo | V. Casado | C. Miró | A. León | Mariano Daz